Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Untangling the ErbB signalling network
2001 Standout
ErbB Receptors: Directing Key Signaling Networks Throughout Life
2004
Cyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long-term Graft Survival as Compared with Sandimmune
2002
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
2006
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Overexpression of HER2/neu oncogene in human pancreatic carcinoma
1993
Gastric cancer
2016 Standout
c-erb B2 amplification and overexpression in human tumors
1991
Identification of Heregulin, a Specific Activator of p185 erbB2
1992 Science
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Primary breast cancer phenotypes associated with propensity for central nervous system metastases
2006
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity
2007
Pancreatic cancer
2004 Standout
Delayed graft function in kidney transplantation
2004 Standout
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer
2015
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Update on Mechanisms of Ischemic Acute Kidney Injury
2006
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
2005
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer
2000
Transforming growth factor α expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma—an immunohistochemical study
1992
Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer
2012
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Advanced pancreatic carcinoma: current treatment and future challenges
2010
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma
1994
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
2008
Esophageal Cancer
2003 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
The epidermal growth factor receptor in human pancreatic cancer
1992
Comparison of the molecular genetics ofc-erb-B2 and p53 expression in stomach cancer in Britain and Japan
1995
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury
2007
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Celiac Disease
2007 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
EGF receptor in neoplasia and metastasis
1993
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons
1996 StandoutNature
The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia
2006
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Prospective, Pilot, Open-Label, Short-Term Study of Conversion to Leflunomide Reverses Chronic Renal Allograft Dysfunction
2002
STATs in oncogenesis
2000 Standout
Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
1998 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status
1999
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
The type 1 (EGFR-related) family of growth factor receptors and their ligands
1992
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Expression of the c‐erbB‐3 gene product in gastric cancer
1993
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Abnormalities of the RB1 and DCC tumor suppressor genes: Uncommon in human pancreatic adenocarcinoma
1995
Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease
1993
The erbB‐3 Gene in human pancreatic cancer
1992
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Accuracy of Testing for Antibodies to Synthetic Gliadin–Related Peptides in Celiac Disease
2006
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER
1996
Genetics and biology of pancreatic ductal adenocarcinoma
2006
Pancreatic cancer
2011 Standout
Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction
1999
K‐ ras oncogene activation in lung adenocarcinomas from former smokers evidence that K‐ ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung
1993
Delayed graft function
2001
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Predicting the future: a critical appraisal of cancer prognosis studies
1999
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy
1994
Bladder Cancer
2020 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
The Cation−π Interaction
1997 Standout
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
1993
Amplification and overexpression of theAKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
1998
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Delayed graft function. Influence on outcome and strategies for prevention.
2001
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
2011
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Molecular Pathogenesis of Pancreatic Cancer
2003
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
1996 StandoutScience
Works of Sunjay Jain being referenced
c‐erbB‐2 proto‐oncogene expression and its relationship to survival in gastric carcinoma: An immunohistochemical study on archival material
1991
Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups
2000
Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients
2000
Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats
2005
Patterns of metastatic breast cancer in relation to histological type
1993
Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer
1991
Rapamycin reduces expression of fibrosis-associated genes in an experimental model of renal ischaemia reperfusion injury
2001
Choosing Health, Choosing Treatment: Patient Choice After Diagnosis of Localized Prostate Cancer
2009
Weekly protocol renal transplant biopsies allow detection of sub-clinical acute rejection episodes in patients with delayed graft function
2000
Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil
2001
Ki-ras oncogene activation in preinvasive pancreatic cancer
1992
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
2017
Molecular changes in extracellular matrix turnover after renal ischaemia–reperfusion injury
2000
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
1991